PFE has already demonstrated an interest in Vascepa by becoming involved with its marketing in Canada...They have had big winners with their CVD drugs, Lipitor and Eliquis....Amarin seems ready for a BO....PFE has plenty of cash and could be a welcome candidate in this regard.